Livzon Pharmaceutical Group Inc. provided earnings guidance for the half year ended June 30, 2016. The company estimates net profit attributable to the shareholders of the company is between RMB 398,786,800 to RMB 426,054,300 against RMB 340,843,400 a year ago. Basic earnings per share is approximately RMB 1.04 to RMB 1.11 against RMB 0.89 a year ago.